| P50 | author | Bert W. O'Malley | Q827492 |
| | Subhamoy Dasgupta | Q42884402 |
| | Akash K Kaushik | Q86697100 |
| P2093 | author name string | Bin Zhang | |
| | Arul M Chinnaiyan | |
| | Erin Stashi | |
| | Jianghua Wang | |
| | Nicholas Mitsiades | |
| | Cristian Coarfa | |
| | Arun Sreekumar | |
| | Nagireddy Putluri | |
| | Kimal Rajapakshe | |
| | Michael M Ittmann | |
| | Weiwen Long | |
| | Christine A Brennan | |
| | James M Arnold | |
| | Salil K Bhowmik | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
| | The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. | Q24537671 |
| | Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 |
| | Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 |
| | Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology | Q27030886 |
| | Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity | Q39190804 |
| | Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line | Q39998829 |
| | Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer | Q40213081 |
| | Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. | Q41779974 |
| | The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells | Q41859976 |
| | Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines | Q42800038 |
| | Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer | Q44018418 |
| | Glutaminolysis activates Rag-mTORC1 signaling. | Q52301079 |
| | Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells | Q73853909 |
| | SRC-1 and TIF2 control energy balance between white and brown adipose tissues | Q78732732 |
| | Phosphoproteomic profiling of in vivo signaling in liver by the mammalian target of rapamycin complex 1 (mTORC1) | Q28478869 |
| | Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells | Q28479062 |
| | The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4 | Q28508613 |
| | SRC-2 is an essential coactivator for orchestrating metabolism and circadian rhythm | Q28511887 |
| | SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism | Q28587694 |
| | Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease | Q28592482 |
| | Bidirectional transport of amino acids regulates mTOR and autophagy | Q29614476 |
| | Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis | Q29615683 |
| | Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia | Q29616650 |
| | Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction | Q29616653 |
| | c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 |
| | Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 |
| | Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 |
| | Integrative genomic profiling of human prostate cancer | Q29619905 |
| | mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway | Q30425628 |
| | The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. | Q33928657 |
| | Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. | Q34451430 |
| | The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles | Q34545963 |
| | Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues | Q34703441 |
| | Nuclear receptor coactivators: master regulators of human health and disease | Q35082574 |
| | 13C isotope-assisted methods for quantifying glutamine metabolism in cancer cells | Q35359580 |
| | Reductive carboxylation supports growth in tumour cells with defective mitochondria. | Q35683311 |
| | Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges | Q35838821 |
| | Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. | Q36517216 |
| | Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids | Q36895786 |
| | Cellular fatty acid metabolism and cancer | Q37092913 |
| | Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif. | Q37310596 |
| | Multi-modulation of nuclear receptor coactivators through posttranslational modifications | Q37329666 |
| | Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells | Q37340612 |
| | Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer | Q37769360 |
| | Cancer cell metabolism: one hallmark, many faces. | Q38046274 |
| | The fat side of prostate cancer | Q38096735 |
| | A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth | Q38299437 |
| | Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. | Q38351123 |
| | In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation | Q39030433 |
| | Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. | Q39149779 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1174-1188 | |
| P577 | publication date | 2015-02-09 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis | |
| P478 | volume | 125 | |